155 related articles for article (PubMed ID: 20339375)
1. Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism.
Zhang GX; Wang BJ; Ouyang JZ; Deng XY; Ma X; Li HZ; Wu Z; Liu SL; Xu H; Zhang X
Hypertens Res; 2010 May; 33(5):478-84. PubMed ID: 20339375
[TBL] [Abstract][Full Text] [Related]
2. Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas.
Wang B; Zhang G; Ouyang J; Deng X; Shi T; Ma X; Li H; Ju Z; Wang C; Wu Z; Liu S; Zhang X
Urology; 2010 Oct; 76(4):1018.e1-7. PubMed ID: 20708777
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production.
Nicod J; Dick B; Frey FJ; Ferrari P
Mol Cell Endocrinol; 2004 Feb; 214(1-2):167-74. PubMed ID: 15062555
[TBL] [Abstract][Full Text] [Related]
4. The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation.
Connell JM; Fraser R; MacKenzie SM; Friel EC; Ingram MC; Holloway CD; Davies E
Mol Cell Endocrinol; 2004 Mar; 217(1-2):243-7. PubMed ID: 15134824
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism.
Takeda Y; Furukawa K; Inaba S; Miyamori I; Mabuchi H
J Clin Endocrinol Metab; 1999 May; 84(5):1633-7. PubMed ID: 10323392
[TBL] [Abstract][Full Text] [Related]
6. Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma.
Yoshii Y; Oki K; Gomez-Sanchez CE; Ohno H; Itcho K; Kobuke K; Yoneda M
Hypertension; 2016 Dec; 68(6):1432-1437. PubMed ID: 27754862
[TBL] [Abstract][Full Text] [Related]
7. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.
Adler G; Widecka K; Peczkowska M; Dobrucki T; Placha G; Drozd R; Parczewski M; Januszewicz A; Gaciong Z; Ciechanowicz A
J Appl Genet; 2005; 46(3):329-32. PubMed ID: 16110193
[TBL] [Abstract][Full Text] [Related]
8. CYP11B2 gene haplotypes independently and in concurrence with aldosterone and aldosterone to renin ratio increase the risk of hypertension.
Nejatizadeh A; Kumar R; Stobdan T; Goyal AK; Gupta M; Tyagi S; Jain SK; Pasha MA
Clin Biochem; 2010 Jan; 43(1-2):136-41. PubMed ID: 19786005
[TBL] [Abstract][Full Text] [Related]
9. Mutations in aldosterone synthase gene of Milan hypertensive rats: phenotypic consequences.
Lloyd-MacGilp SA; Torielli L; Bechtel S; Tripodi G; Gomez-Sanchez CE; Zagato L; Bernhardt R; Kenyon CJ
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E608-17. PubMed ID: 11832364
[TBL] [Abstract][Full Text] [Related]
10. Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension.
Tsukada K; Ishimitsu T; Teranishi M; Saitoh M; Yoshii M; Inada H; Ohta S; Akashi M; Minami J; Ono H; Ohrui M; Matsuoka H
J Hum Hypertens; 2002 Nov; 16(11):789-93. PubMed ID: 12444540
[TBL] [Abstract][Full Text] [Related]
11. Association of the -344C/T aldosterone synthase (CYP11B2) gene variant with hypertension and stroke.
Munshi A; Sharma V; Kaul S; Rajeshwar K; Babu MS; Shafi G; Anila AN; Balakrishna N; Alladi S; Jyothy A
J Neurol Sci; 2010 Sep; 296(1-2):34-8. PubMed ID: 20598712
[TBL] [Abstract][Full Text] [Related]
12. [A related analysis for alpha, beta fibrinogen gene haplotypes and nucleotide polymorphisms associated with the ischemic stroke in Hainan Han population].
Liang L; Sun C; Liao XP; Xiao F; Chen XD; Huang SX; Tang XL; Wen GQ; Long ZG; Wang XY; Liu GX; Cheng S; Cai WW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):316-9. PubMed ID: 16767673
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic variation of CYP11B2 predicts postoperative resolution of hypertension in patients undergoing adrenalectomy for aldosterone-producing adenomas.
Wang W; Hu WL; Zhang LC; Xiao YS; Liu J; Bin C
Int J Urol; 2012 Sep; 19(9):813-20. PubMed ID: 22650983
[TBL] [Abstract][Full Text] [Related]
14. Mutations in CYP11B1 gene converting 11beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas.
Pilon C; Mulatero P; Barzon L; Veglio F; Garrone C; Boscaro M; Sonino N; Fallo F
J Clin Endocrinol Metab; 1999 Nov; 84(11):4228-31. PubMed ID: 10566677
[TBL] [Abstract][Full Text] [Related]
15. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia.
Pakakasama S; Sirirat T; Kanchanachumpol S; Udomsubpayakul U; Mahasirimongkol S; Kitpoka P; Thithapandha A; Hongeng S
Pediatr Blood Cancer; 2007 Jan; 48(1):16-20. PubMed ID: 16435384
[TBL] [Abstract][Full Text] [Related]
17. CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism.
Mulatero P; Schiavone D; Fallo F; Rabbia F; Pilon C; Chiandussi L; Pascoe L; Veglio F
Hypertension; 2000 Mar; 35(3):694-8. PubMed ID: 10720580
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism.
Oda N; Takeda Y; Zhu A; Usukura M; Yoneda T; Takata H; Mabuchi H
Hypertens Res; 2006 Jan; 29(1):9-14. PubMed ID: 16715648
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree.
Pascoe L; Jeunemaitre X; Lebrethon MC; Curnow KM; Gomez-Sanchez CE; Gasc JM; Saez JM; Corvol P
J Clin Invest; 1995 Nov; 96(5):2236-46. PubMed ID: 7593610
[TBL] [Abstract][Full Text] [Related]
20. Haplotype analysis of CYP11B2.
White PC; Slutsker L
Endocr Res; 1995; 21(1-2):437-42. PubMed ID: 7588407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
